Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis

Published:2008-02 Issue:1 Volume:18 Page:34-44
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Saito Eizo,Koike Takao,Hashimoto Hiroshi,Miyasaka Nobuyuki,Ikeda Yasuo,Hara Masako,Yamada Hidehiro,Yoshida Tadashi,Harigai Masayoshi,Ichikawa Yoichi,

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

http://www.tandfonline.com/doi/pdf/10.3109/s10165-007-0013-0

Reference36 articles.

1. Recognition and Management of Myositis

2. Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain.

3. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.

4. Effects of Intravenous Immunoglobulins (IVIG) on Peripheral Blood B, NK, and T Cell Subpopulations in Women with Recurrent Spontaneous Abortions: Specific Effects on LFA-1 and CD56 Molecules

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous Immunoglobulins in Idiopathic Inflammatory Myopathies: Where Are We?;Current Treatment Options in Rheumatology;2024-01-10

2. Diagnosis and Management of Myositis-Associated Lung Disease;Chest;2023-06

3. Trial of Intravenous Immune Globulin in Dermatomyositis;New England Journal of Medicine;2022-10-06

4. Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: Results of a multicentric study;Autoimmunity Reviews;2021-03

5. Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study;Rheumatology;2020-10-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3